Latest Prodrugs Stories
A biomarker reflecting expression levels of two genes in tumor tissue may be able to predict which women treated for estrogen-receptor (ER)-positive breast cancer should receive a second estrogen-blocking medication after completing tamoxifen treatment.
One of the largest clinical trials done in infants with congenital (present at birth) heart diseases.
A missing brain enzyme increases concentrations of a protein related to pain-killer addiction.
New research from the Mayo Clinic has identified favorable genetic variations that increase the chances of a positive response to preventive breast cancer therapy with the drugs tamoxifen and raloxifene.
Prescription drugs are so addictive that when teens begin to abuse them, they can quickly spiral into high levels of abuse and addiction.
The Cardiovascular Research Laboratory of the IDIBELL led by the cardiologist of the Bellvitge University Hospital José Luis Ferreiro has conducted a study on the effect of antiplatelet drugs given to high risk patients suffering from acute myocardial infaction (heart attack) in the context of the Infarction Code.